Grants and Contributions:

Back to search
Title:
C2MN (Canadian Cell Manufacturing Network): A Collaborative Approach to Building Point-of-Care Manufacturing in Support of Early Phase Clinical Trials
Agreement Number:
980184
Agreement Value:
$1,471,765.00
Agreement Date:
Apr 1, 2021 - Oct 31, 2022
Description:
This project builds on the success of the work done over the last two years in establishing clinical grade manufacturing for both lentivirus and cell products, and in executing the first clinical trial using a made-in-Canada CD19 CAR T-cell therapy. The goal over the next 18 months is to build much-needed capacity in point-of-care (POC) manufacturing to support the clinical roll-out of novel CAR T-cell products and other personalized cell therapy products with the addition of three new POC manufacturing and clinical sites across Canada. In parallel, and with direct involvement of the NRC, it will be aimed to initiate a minimum of two new, high-content, academically motivated clinical trials to be started by the end of the project and completed with the next five years for the benefit of cancer patients from across Canada.
Organization:
National Research Council Canada
Expected Results:

In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.

Location:
Vancouver, British Columbia, CA V5Z 4E6
Reference Number:
172-2021-2022-Q2-980184
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
863530135
Recipient Type:
Not-for-profit organization or charity
Recipient's Legal Name:
BC Cancer, part of the Provincial Health Services Authority
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:

Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.

NAICS Code:
541710